Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × decitabine and cedazuridine drug combination × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Myelodysplastic Syndromes 8 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 4 Myelodysplastic-Myeloproliferative Diseases 2 Anemia, Refractory, with Excess of Blasts 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neurofibrosarcoma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 GATA2 Deficiency 1 Carcinoma, Merkel Cell 1 BRCA1 Mutation 1 Allogeneic Stem Cell Transplantation 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡